375 related articles for article (PubMed ID: 23283968)
1. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain.
Zigdon H; Kogot-Levin A; Park JW; Goldschmidt R; Kelly S; Merrill AH; Scherz A; Pewzner-Jung Y; Saada A; Futerman AH
J Biol Chem; 2013 Feb; 288(7):4947-56. PubMed ID: 23283968
[TBL] [Abstract][Full Text] [Related]
2. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
Stiban J; Perera M
Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
[TBL] [Abstract][Full Text] [Related]
3. Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.
Park WJ; Park JW; Erez-Roman R; Kogot-Levin A; Bame JR; Tirosh B; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
J Biol Chem; 2013 Oct; 288(43):30904-16. PubMed ID: 24019516
[TBL] [Abstract][Full Text] [Related]
4. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY.
Novgorodov SA; Riley CL; Keffler JA; Yu J; Kindy MS; Macklin WB; Lombard DB; Gudz TI
J Biol Chem; 2016 Jan; 291(4):1957-1973. PubMed ID: 26620563
[TBL] [Abstract][Full Text] [Related]
6. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.
Imgrund S; Hartmann D; Farwanah H; Eckhardt M; Sandhoff R; Degen J; Gieselmann V; Sandhoff K; Willecke K
J Biol Chem; 2009 Nov; 284(48):33549-60. PubMed ID: 19801672
[TBL] [Abstract][Full Text] [Related]
7. Long-Chain and Very Long-Chain Ceramides Mediate Doxorubicin-Induced Toxicity and Fibrosis.
Kretzschmar T; Bekhite MM; Wu JMF; Haase D; Förster M; Müller T; Nietzsche S; Westermann M; Franz M; Gräler MH; Schulze PC
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769283
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis.
Volpert G; Ben-Dor S; Tarcic O; Duan J; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
J Cell Sci; 2017 Apr; 130(8):1486-1493. PubMed ID: 28280117
[TBL] [Abstract][Full Text] [Related]
9. Altering sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via K(Ca) 1.1 upregulation.
Choi S; Kim JA; Kim TH; Li HY; Shin KO; Lee YM; Oh S; Pewzner-Jung Y; Futerman AH; Suh SH
Aging Cell; 2015 Dec; 14(6):982-94. PubMed ID: 26288989
[TBL] [Abstract][Full Text] [Related]
10. Development of pheochromocytoma in ceramide synthase 2 null mice.
Park WJ; Brenner O; Kogot-Levin A; Saada A; Merrill AH; Pewzner-Jung Y; Futerman AH
Endocr Relat Cancer; 2015 Aug; 22(4):623-32. PubMed ID: 26113602
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length.
Park WJ; Park JW; Merrill AH; Storch J; Pewzner-Jung Y; Futerman AH
Biochim Biophys Acta; 2014 Dec; 1841(12):1754-66. PubMed ID: 25241943
[TBL] [Abstract][Full Text] [Related]
12. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione.
García-Ruiz C; Colell A; Marí M; Morales A; Fernández-Checa JC
J Biol Chem; 1997 Apr; 272(17):11369-77. PubMed ID: 9111045
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
14. Widespread tissue distribution and synthetic pathway of polyunsaturated C24:2 sphingolipids in mammals.
Edagawa M; Sawai M; Ohno Y; Kihara A
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Dec; 1863(12):1441-1448. PubMed ID: 30251650
[TBL] [Abstract][Full Text] [Related]
15. Ceramide synthase 2-C
Zhang X; Sakamoto W; Canals D; Ishibashi M; Matsuda M; Nishida K; Toyoshima M; Shigeta S; Taniguchi M; Senkal CE; Okazaki T; Yaegashi N; Hannun YA; Nabe T; Kitatani K
FASEB J; 2021 Feb; 35(2):e21287. PubMed ID: 33423335
[TBL] [Abstract][Full Text] [Related]
16. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
[TBL] [Abstract][Full Text] [Related]
17. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
18. A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy.
Pewzner-Jung Y; Brenner O; Braun S; Laviad EL; Ben-Dor S; Feldmesser E; Horn-Saban S; Amann-Zalcenstein D; Raanan C; Berkutzki T; Erez-Roman R; Ben-David O; Levy M; Holzman D; Park H; Nyska A; Merrill AH; Futerman AH
J Biol Chem; 2010 Apr; 285(14):10911-23. PubMed ID: 20110366
[TBL] [Abstract][Full Text] [Related]
19. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
[TBL] [Abstract][Full Text] [Related]
20. Altering the sphingolipid acyl chain composition prevents LPS/GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization.
Ali M; Fritsch J; Zigdon H; Pewzner-Jung Y; Schütze S; Futerman AH
Cell Death Dis; 2013 Nov; 4(11):e929. PubMed ID: 24263103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
